Sakar Healthcare Limited
Indian Pharmaceutical Exporter Β· Advanced Antibiotics Specialist Β· $16.0M Total Trade Β· DGFT Verified
Sakar Healthcare Limited is an Indian pharmaceutical exporter with a total trade value of $16.0M across 6 products in 4 therapeutic categories. Based on 352 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Cefixime ($4.5M), Ceftriaxone ($4.2M), Heparin ($4.0M).
Sakar Healthcare Limited β Export Portfolio & Destination Treemap

Who is Sakar Healthcare Limited? β Company Overview & Market Position
Sakar Healthcare Limited, established on March 26, 2004, is a public limited company headquartered in Ahmedabad, Gujarat, India. The company specializes in the research, development, manufacturing, and marketing of a diverse range of pharmaceutical formulations, including liquid orals, cephalosporin tablets, capsules, dry powder syrups, injections, and lyophilized injections. Its product portfolio spans various therapeutic areas such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaesthetic, bronchodilator, adrenergic, sedative, anti-inflammatory, antiemetic, anticonvulsant, antipsychotic, antidepressant, and anti-cancer.
The company is listed on the National Stock Exchange of India under the ticker symbol SAKAR. As of January 1, 2026, Sakar Healthcare Limited has a market capitalization of approximately βΉ8.92 billion (INR), equivalent to about $99.2 million USD. In the fiscal year ending March 31, 2025, the company reported a revenue of βΉ1.78 billion, marking a 15.53% increase from the previous year. The workforce comprises approximately 342 employees.